Applied Genetic Technologies Corporation (NASDAQ: AGTC) flaunted slowness of -4.87% at $4.10, as the Stock market unbolted on May 19, 2021. During the day, the stock rose to $4.285 and sunk to $4.0299 before settling in for the price of $4.31 at the close. Taking a more long-term approach, AGTC posted a 52-week range of $3.53-$9.67.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.80%. Meanwhile, its Annual Earning per share during the time was -7.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 9.70%. This publicly-traded company’s shares outstanding now amounts to $42.75 million, simultaneously with a float of $36.27 million. The organization now has a market capitalization sitting at $165.48 million. At the time of writing, stock’s 50-day Moving Average stood at $4.53, while the 200-day Moving Average is $4.94.
Let’s gauge the efficiency of the firm, which has a total of 83 employees. It has generated 29,554 per worker during the last fiscal year. Meanwhile, its income per employee was -552,916. The stock had 377.38 Receivables turnover and 0.03 Total Asset turnover. For the Profitability, stocks operating margin was -1913.66 and Pretax Margin of -1865.55.
Applied Genetic Technologies Corporation (AGTC) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Applied Genetic Technologies Corporation industry. Applied Genetic Technologies Corporation’s current insider ownership accounts for 0.66%, in contrast to 57.10% institutional ownership.
Applied Genetic Technologies Corporation (AGTC) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 3/30/2021, it has been observed that the corporation posted -$0.4 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.41) by $0.01. This company achieved a net margin of -1870.85 while generating a return on equity of -61.30. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
Applied Genetic Technologies Corporation’s EPS increase for this current 12-month fiscal period is 9.70% and is forecasted to reach -1.70 in the upcoming year.
Applied Genetic Technologies Corporation (NASDAQ: AGTC) Trading Performance Indicators
Let’s observe the current performance indicators for Applied Genetic Technologies Corporation (AGTC). It’s Quick Ratio in the last reported quarter now stands at 3.90. The Stock has managed to achieve an average true range (ATR) of 0.31.
In the same vein, AGTC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.26, a figure that is expected to reach -0.41 in the next quarter, and analysts are predicting that it will be -1.70 at the market close of one year from today.
Technical Analysis of Applied Genetic Technologies Corporation (AGTC)
Now, what If we examine the latest scores posted by [Applied Genetic Technologies Corporation, AGTC]. During the last 5-days, its volume was lower the volume of 2.53 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 71.23% While, its Average True Range was 0.31.
Raw Stochastic average of Applied Genetic Technologies Corporation (AGTC) in the period of the previous 100 days is set at 9.28%, which indicates a major fall in contrast to 64.04% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 72.85% that was lower than 101.40% volatility it exhibited in the past 100-days period.